{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:23:58Z","timestamp":1790688238043,"version":"4.1.0"},"reference-count":143,"publisher":"European Respiratory Society (ERS)","issue":"149","content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2018,7,13]]},"published-print":{"date-parts":[[2018,9,30]]},"abstract":"<jats:p>Human primary immunodeficiency diseases (PIDs) represent a heterogeneous group of more than 350 disorders. They are rare diseases, but their global incidence is more relevant than generally thought. The underlying defect may involve different branches of the innate and\/or adaptive immune response. Thus, the clinical picture may range from severe phenotypes characterised by a broad spectrum of infections to milder infectious phenotypes due to more selective (and frequent) immune defects. Moreover, infections may not be the main clinical features in some PIDs that might present with autoimmunity, auto-inflammation and\/or cancer. Primary antibody deficiencies (PADs) represent a small percentage of the known PIDs but they are the most frequently diagnosed, particularly in adulthood. Common variable immunodeficiency (CVID) is the most prevalent symptomatic PAD.<\/jats:p>\n                  <jats:p>PAD patients share a significant susceptibility to respiratory diseases that represent a relevant cause of morbidity and mortality. Pulmonary complications include acute and chronic infection-related diseases, such as pneumonia and bronchiectasis. They also include immune-mediated interstitial lung diseases, such as granulomatous-lymphocytic interstitial lung disease (GLILD) and cancer. Herein we will discuss the main pulmonary manifestations of PADs, the associated functional and imaging findings, and the relevant role of pulmonologists and chest radiologists in diagnosis and surveillance.<\/jats:p>","DOI":"10.1183\/16000617.0019-2018","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T06:46:58Z","timestamp":1535525218000},"page":"180019","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":70,"title":["The broad spectrum of lung diseases in primary antibody deficiencies"],"prefix":"10.1183","volume":"27","author":[{"given":"Francesco","family":"Cinetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Rattazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Agostini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2018,8,29]]},"reference":[{"key":"2024102403355133000_27.149.180019.1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0464-9"},{"key":"2024102403355133000_27.149.180019.2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0465-8"},{"key":"2024102403355133000_27.149.180019.3","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s10875-014-0102-8","article-title":"Prevalence and morbidity of primary immunodeficiency diseases, United States 2001\u20132007","volume":"34","author":"Kobrynski","year":"2014","journal-title":"J Clin Immunol"},{"key":"2024102403355133000_27.149.180019.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-012-9751-7","article-title":"Primary immunodeficiency diseases worldwide: more common than generally thought","volume":"33","author":"Bousfiha","year":"2013","journal-title":"J Clin Immunol"},{"key":"2024102403355133000_27.149.180019.5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3389\/fimmu.2016.00365","article-title":"Cancers related to immunodeficiencies: update and perspectives","volume":"7","author":"Mortaz","year":"2016","journal-title":"Front Immunol"},{"key":"2024102403355133000_27.149.180019.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-05-431064"},{"key":"2024102403355133000_27.149.180019.7","doi-asserted-by":"publisher","DOI":"10.1038\/nri3466"},{"key":"2024102403355133000_27.149.180019.8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.crad.2011.10.028","article-title":"Respiratory disease in common variable immunodeficiency and other primary immunodeficiency disorders","volume":"67","author":"Hampson","year":"2012","journal-title":"Clin Radiol"},{"key":"2024102403355133000_27.149.180019.9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International Consensus Document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102403355133000_27.149.180019.10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11882-016-0597-6","article-title":"Autoimmune and lymphoproliferative complications of common variable immunodeficiency","volume":"16","author":"Maglione","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"2024102403355133000_27.149.180019.11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10875-014-0009-4","article-title":"Association between IgA deficiency and other autoimmune conditions: a population-based matched cohort study","volume":"34","author":"Ludvigsson","year":"2014","journal-title":"J Clin Immunol"},{"key":"2024102403355133000_27.149.180019.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.05.046"},{"key":"2024102403355133000_27.149.180019.13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s11882-008-0078-7","article-title":"Autosomal recessive agammaglobulinemia: novel insights from mutations in Ig-beta","volume":"8","author":"Lougaris","year":"2008","journal-title":"Curr Allergy Asthma Rep"},{"key":"2024102403355133000_27.149.180019.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2011.04377.x"},{"key":"2024102403355133000_27.149.180019.15","doi-asserted-by":"publisher","DOI":"10.1097\/01.md.0000229482.27398.ad"},{"key":"2024102403355133000_27.149.180019.16","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.jaip.2016.08.005","article-title":"Lung disease in primary antibody deficiencies","volume":"4","author":"Schussler","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102403355133000_27.149.180019.17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cei.13068","article-title":"Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy","volume":"191","author":"Stubbs","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"2024102403355133000_27.149.180019.18","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2002.5241"},{"key":"2024102403355133000_27.149.180019.19","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jaip.2016.09.013","article-title":"Clinical phenotypes of hyper-IgM syndromes","volume":"4","author":"de la Morena","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102403355133000_27.149.180019.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08077.x"},{"key":"2024102403355133000_27.149.180019.21","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0b013e3283594219"},{"key":"2024102403355133000_27.149.180019.22","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-009-9357-x"},{"key":"2024102403355133000_27.149.180019.23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s10875-015-0230-9","article-title":"Risk of infections among 2100 individuals with IgA deficiency: a nationwide cohort study","volume":"36","author":"Ludvigsson","year":"2016","journal-title":"J Clin Immunol"},{"key":"2024102403355133000_27.149.180019.24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cellimm.2015.09.004","article-title":"Selective subnormal IgG3 in 121 adult index patients with frequent or severe bacterial respiratory tract infections","volume":"299","author":"Barton","year":"2016","journal-title":"Cell Immunol"},{"key":"2024102403355133000_27.149.180019.25","doi-asserted-by":"crossref","first-page":"1405950","DOI":"10.1155\/2016\/1405950","article-title":"Selective subnormal IgG1 in 54 adult index patients with frequent or severe bacterial respiratory tract infections","volume":"2016","author":"Barton","year":"2016","journal-title":"J Immunol Res"},{"key":"2024102403355133000_27.149.180019.26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.iac.2015.07.003","article-title":"Specific antibody deficiencies","volume":"35","author":"Wall","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"2024102403355133000_27.149.180019.27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.18176\/jiaci.0069","article-title":"T-cell abnormalities in common variable immunodeficiency","volume":"26","author":"Azizi","year":"2016","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2024102403355133000_27.149.180019.28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S2213-2600(15)00202-7","article-title":"Lung disease in primary antibody deficiency","volume":"3","author":"Verma","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2024102403355133000_27.149.180019.29","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-011-9511-0"},{"key":"2024102403355133000_27.149.180019.30","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12748"},{"key":"2024102403355133000_27.149.180019.31","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2771"},{"key":"2024102403355133000_27.149.180019.32","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3746"},{"key":"2024102403355133000_27.149.180019.33","doi-asserted-by":"publisher","DOI":"10.1126\/science.1243292"},{"key":"2024102403355133000_27.149.180019.34","doi-asserted-by":"publisher","DOI":"10.1126\/science.1255904"},{"key":"2024102403355133000_27.149.180019.35","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3040"},{"key":"2024102403355133000_27.149.180019.36","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00173410"},{"key":"2024102403355133000_27.149.180019.37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.rmed.2017.10.016","article-title":"Primary immune deficiency diseases as unrecognized causes of chronic respiratory disease","volume":"132","author":"Berger","year":"2017","journal-title":"Respir Med"},{"key":"2024102403355133000_27.149.180019.38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2500\/aap.2016.37.4007","article-title":"Pulmonologist perspectives regarding diagnosis and management of primary immunodeficiency diseases","volume":"37","author":"Orange","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"2024102403355133000_27.149.180019.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03851.x"},{"key":"2024102403355133000_27.149.180019.40","doi-asserted-by":"publisher","DOI":"10.1159\/000301584"},{"key":"2024102403355133000_27.149.180019.41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/1040841X.2016.1268568","article-title":"Chronic lung disease in common variable immune deficiency (CVID): a pathophysiological role for microbial and non-B cell immune factors","volume":"43","author":"Mooney","year":"2017","journal-title":"Crit Rev Microbiol"},{"key":"2024102403355133000_27.149.180019.42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/path.4812","article-title":"The burgeoning field of innate immune-mediated disease and autoinflammation","volume":"241","author":"Peckham","year":"2017","journal-title":"J Pathol"},{"key":"2024102403355133000_27.149.180019.43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10875-013-9942-x","article-title":"Activity, severity and impact of respiratory disease in primary antibody deficiency syndromes","volume":"34","author":"Hurst","year":"2014","journal-title":"J Clin Immunol"},{"key":"2024102403355133000_27.149.180019.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.02.040"},{"key":"2024102403355133000_27.149.180019.45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaip.2017.05.024","article-title":"Respiratory infections and antibiotic usage in common variable immunodeficiency","volume":"6","author":"Sperlich","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102403355133000_27.149.180019.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.12.1077"},{"key":"2024102403355133000_27.149.180019.47","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2016.07.012","article-title":"Development and initial validation of a questionnaire to measure health-related quality of life of adults with common variable immune deficiency: the CVID_QoL questionnaire","volume":"4","author":"Quinti","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102403355133000_27.149.180019.48","unstructured":"Jeffrey Modell Foundation. 10 Warning Signs www.info4pi.org\/library\/educational-materials\/10-warning-signs Date last updated: September 29, 2016. Date last accessed: August 19, 2018."},{"key":"2024102403355133000_27.149.180019.49","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2011.06206.x"},{"key":"2024102403355133000_27.149.180019.50","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-254417"},{"key":"2024102403355133000_27.149.180019.51","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-8244(03)00304-3"},{"key":"2024102403355133000_27.149.180019.52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/cei.12600","article-title":"Immune deficiency: changing spectrum of pathogens","volume":"181","author":"Duraisingham","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"2024102403355133000_27.149.180019.53","doi-asserted-by":"crossref","first-page":"213","DOI":"10.18176\/jiaci.0166","article-title":"Infectious and noninfectious pulmonary complications in patients with primary immunodeficiency disorders","volume":"27","author":"Yazdani","year":"2017","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2024102403355133000_27.149.180019.54","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.159.4.9807067"},{"key":"2024102403355133000_27.149.180019.55","doi-asserted-by":"publisher","DOI":"10.1086\/587669"},{"key":"2024102403355133000_27.149.180019.56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fped.2014.00077","article-title":"Pulmonary manifestations of primary immunodeficiency disorders in children","volume":"2","author":"Jesenak","year":"2014","journal-title":"Front Pediatr"},{"key":"2024102403355133000_27.149.180019.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.04.016"},{"key":"2024102403355133000_27.149.180019.58","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000355957","article-title":"Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports","volume":"163","author":"Kralickova","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"2024102403355133000_27.149.180019.59","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00001-09"},{"key":"2024102403355133000_27.149.180019.60","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.anai.2013.10.008","article-title":"X-linked agammaglobulinemia presenting as polymicrobial pneumonia, including Pneumocystis jirovecii","volume":"112","author":"Jongco","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2024102403355133000_27.149.180019.61","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.jaci.2011.03.041","article-title":"Longitudinal decline in lung function in patients with primary immunoglobulin deficiencies","volume":"127","author":"Chen","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2024102403355133000_27.149.180019.62","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.clim.2017.07.008","article-title":"X-linked agammaglobulinaemia: outcomes in the modern era","volume":"183","author":"Shillitoe","year":"2017","journal-title":"Clin Immunol"},{"key":"2024102403355133000_27.149.180019.63","first-page":"427","article-title":"Assessment of nutritional status: vitamin A and zinc in patients with common variable immunodeficiency","volume":"22","author":"dos Santos-Valente","year":"2012","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2024102403355133000_27.149.180019.64","doi-asserted-by":"publisher","DOI":"10.1309\/AJCPEIILH2C0WFYE"},{"key":"2024102403355133000_27.149.180019.65","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cei.12172","article-title":"The United Kingdom Primary Immune Deficiency (UKPID) Registry: report of the first 4 years\u2019 activity 2008\u20132012","volume":"175","author":"Edgar","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2024102403355133000_27.149.180019.66","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.5.9908022"},{"key":"2024102403355133000_27.149.180019.67","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00170014"},{"key":"2024102403355133000_27.149.180019.68","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3410\/M1-67","article-title":"Non-cystic fibrosis bronchiectasis: review and recent advances","volume":"1","author":"Livnat","year":"2009","journal-title":"F1000 Med Rep"},{"key":"2024102403355133000_27.149.180019.69","first-page":"6","article-title":"Inflammation: a two-edged sword \u2013 the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"key":"2024102403355133000_27.149.180019.70","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ccm.2015.11.005","article-title":"Using cystic fibrosis therapies for non-cystic fibrosis bronchiectasis","volume":"37","author":"ElMaraachli","year":"2016","journal-title":"Clin Chest Med"},{"key":"2024102403355133000_27.149.180019.71","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jaip.2017.11.024","article-title":"Should antibiotic prophylaxis be routinely used in patients with antibody-mediated primary immunodeficiency?","volume":"6","author":"Ballow","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102403355133000_27.149.180019.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.04.049"},{"key":"2024102403355133000_27.149.180019.73","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2249.2007.03550.x","article-title":"Serial lung function tests in primary immune deficiency","volume":"151","author":"Rich","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2024102403355133000_27.149.180019.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2007.06.007"},{"key":"2024102403355133000_27.149.180019.75","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.apmr.2016.05.017","article-title":"Pulmonary rehabilitation in individuals with non-cystic fibrosis bronchiectasis: a systematic review","volume":"98","author":"Lee","year":"2017","journal-title":"Arch Phys Med Rehabil"},{"key":"2024102403355133000_27.149.180019.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2014.03.003"},{"key":"2024102403355133000_27.149.180019.77","doi-asserted-by":"crossref","first-page":"e90047","DOI":"10.1371\/journal.pone.0090047","article-title":"Macrolide therapy in adults and children with non-cystic fibrosis bronchiectasis: a systematic review and meta-analysis","volume":"9","author":"Gao","year":"2014","journal-title":"PLoS One"},{"key":"2024102403355133000_27.149.180019.78","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1546752"},{"key":"2024102403355133000_27.149.180019.79","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.mayocp.2013.05.021","article-title":"Asthma and risk of selective IgA deficiency or common variable immunodeficiency: a population-based case-control study","volume":"88","author":"Urm","year":"2013","journal-title":"Mayo Clin Proc"},{"key":"2024102403355133000_27.149.180019.80","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.aller.2013.09.014","article-title":"Bronchial hyperreactivity in children with antibody deficiencies","volume":"43","author":"Ozcan","year":"2015","journal-title":"Allergol Immunopathol (Madr)"},{"key":"2024102403355133000_27.149.180019.81","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3346\/jkms.2016.31.10.1560","article-title":"Immunoglobulin G subclass deficiencies in adult patients with chronic airway diseases","volume":"31","author":"Kim","year":"2016","journal-title":"J Korean Med Sci"},{"key":"2024102403355133000_27.149.180019.82","doi-asserted-by":"crossref","first-page":"e0172437","DOI":"10.1371\/journal.pone.0172437","article-title":"Antibody deficiency in patients with frequent exacerbations of chronic obstructive pulmonary disease (COPD)","volume":"12","author":"McCullagh","year":"2017","journal-title":"PLoS One"},{"key":"2024102403355133000_27.149.180019.83","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4168\/aair.2017.9.6.526","article-title":"Effects of immunoglobulin replacement on asthma exacerbation in adult asthmatics with IgG subclass deficiency","volume":"9","author":"Kim","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"2024102403355133000_27.149.180019.84","first-page":"53","article-title":"The response to intravenous immunoglobulin replacement therapy in patients with asthma with specific antibody deficiency","volume":"27","author":"Schwartz","year":"2006","journal-title":"Allergy Asthma Proc"},{"key":"2024102403355133000_27.149.180019.85","doi-asserted-by":"crossref","first-page":"e0142205","DOI":"10.1371\/journal.pone.0142205","article-title":"A retrospective longitudinal within-subject risk interval analysis of immunoglobulin treatment for recurrent acute exacerbation of chronic obstructive pulmonary disease","volume":"10","author":"Cowan","year":"2015","journal-title":"PLoS One"},{"key":"2024102403355133000_27.149.180019.86","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s10875-016-0264-7","article-title":"Secondary antibody deficiency in glucocorticoid therapy clearly differs from primary antibody deficiency","volume":"36","author":"Wirsum","year":"2016","journal-title":"J Clin Immunol"},{"key":"2024102403355133000_27.149.180019.87","first-page":"419","article-title":"An approach to interpreting restrictive spirometric pattern results in occupational settings","volume":"107","author":"Tafuro","year":"2016","journal-title":"Med Lav"},{"key":"2024102403355133000_27.149.180019.88","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.5.1594"},{"key":"2024102403355133000_27.149.180019.89","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e3283642c47"},{"key":"2024102403355133000_27.149.180019.90","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaci.2013.08.022","article-title":"Tertiary lymphoid neogenesis is a component of pulmonary lymphoid hyperplasia in patients with common variable immunodeficiency","volume":"133","author":"Maglione","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"2024102403355133000_27.149.180019.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.04.015"},{"key":"2024102403355133000_27.149.180019.92","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0121-5"},{"key":"2024102403355133000_27.149.180019.93","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.humpath.2015.05.011","article-title":"Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency \u2013 histologic and immunohistochemical analyses of 16 cases","volume":"46","author":"Rao","year":"2015","journal-title":"Hum Pathol"},{"key":"2024102403355133000_27.149.180019.94","doi-asserted-by":"publisher","DOI":"10.1378\/chest.100.2.552"},{"key":"2024102403355133000_27.149.180019.95","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-008905"},{"key":"2024102403355133000_27.149.180019.96","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9755-3"},{"key":"2024102403355133000_27.149.180019.97","first-page":"620","article-title":"LPS-responsive beige-like anchor gene mutation associated with possible bronchiolitis obliterans organizing pneumonia associated with hypogammaglobulinemia and normal IgM phenotype and low number of B cells","volume":"54","author":"Shokri","year":"2016","journal-title":"Acta Med Iran"},{"key":"2024102403355133000_27.149.180019.98","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-011-2191-6"},{"key":"2024102403355133000_27.149.180019.99","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)32278-7"},{"key":"2024102403355133000_27.149.180019.100","first-page":"91","article-title":"Sarcoidosis and primary hypogammaglobulinaemia: a report of two cases and a review of the literature","volume":"2","author":"Leen","year":"1985","journal-title":"Sarcoidosis"},{"key":"2024102403355133000_27.149.180019.101","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.05.057"},{"key":"2024102403355133000_27.149.180019.102","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.10.002"},{"key":"2024102403355133000_27.149.180019.103","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaip.2017.01.021","article-title":"British Lung Foundation\/United Kingdom Primary Immunodeficiency Network Consensus Statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders","volume":"5","author":"Hurst","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102403355133000_27.149.180019.104","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-005-0008-x"},{"key":"2024102403355133000_27.149.180019.105","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00189011"},{"key":"2024102403355133000_27.149.180019.106","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1376862"},{"key":"2024102403355133000_27.149.180019.107","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050381"},{"key":"2024102403355133000_27.149.180019.108","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.05.001"},{"key":"2024102403355133000_27.149.180019.109","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/1744666X.2016.1181541","article-title":"Advances in understanding the immunopathology of sarcoidosis and implications on therapy","volume":"12","author":"Cinetto","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"2024102403355133000_27.149.180019.110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2249.2011.04425.x","article-title":"Airway and interstitial lung disease are distinct entities in paediatric common variable immunodeficiency","volume":"165","author":"van de Ven","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"2024102403355133000_27.149.180019.111","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1513\/AnnalsATS.201511-728OC","article-title":"Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease","volume":"13","author":"Mannina","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"2024102403355133000_27.149.180019.112","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-091744"},{"key":"2024102403355133000_27.149.180019.113","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00170013"},{"key":"2024102403355133000_27.149.180019.114","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00025513"},{"key":"2024102403355133000_27.149.180019.115","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3389\/fimmu.2017.01130","article-title":"Mass cytometry identifies distinct lung CD4(+) T Cell patterns in Lofgren's syndrome and non-Lofgren's syndrome sarcoidosis","volume":"8","author":"Kaiser","year":"2017","journal-title":"Front Immunol"},{"key":"2024102403355133000_27.149.180019.116","first-page":"913","article-title":"How might transbronchial cryobiopsy improve diagnosis and treatment of diffuse parenchymal lung disease patients?","volume":"11","author":"Poletti","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"2024102403355133000_27.149.180019.117","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.anai.2017.01.004","article-title":"Predictors of granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"118","author":"Hartono","year":"2017","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2024102403355133000_27.149.180019.118","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaip.2015.07.004","article-title":"Progression of common variable immunodeficiency interstitial lung disease accompanies distinct pulmonary and laboratory findings","volume":"3","author":"Maglione","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2024102403355133000_27.149.180019.119","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"2024102403355133000_27.149.180019.120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.anai.2010.04.015","article-title":"Development of pulmonary abnormalities in patients with common variable immunodeficiency: associations with clinical and immunologic factors","volume":"104","author":"Gregersen","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2024102403355133000_27.149.180019.121","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.crad.2017.03.018","article-title":"Humoral primary immunodeficiency diseases: clinical overview and chest high-resolution computed tomography (HRCT) features in the adult population","volume":"72","author":"Cereser","year":"2017","journal-title":"Clin Radiol"},{"key":"2024102403355133000_27.149.180019.122","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/cei.12856","article-title":"FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID)","volume":"187","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"2024102403355133000_27.149.180019.123","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.029819"},{"key":"2024102403355133000_27.149.180019.124","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2004.02.011"},{"key":"2024102403355133000_27.149.180019.125","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9778-9"},{"key":"2024102403355133000_27.149.180019.126","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1002\/ppul.23757","article-title":"Efficacy of mycophenolate on lung disease and autoimmunity in children with immunodeficiency","volume":"52","author":"Bucciol","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"2024102403355133000_27.149.180019.127","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2005.02220.x"},{"key":"2024102403355133000_27.149.180019.128","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s00415-013-6987-y","article-title":"Changes in regulatory T cells after rituximab in two patients with refractory myasthenia gravis","volume":"260","author":"Catzola","year":"2013","journal-title":"J Neurol"},{"key":"2024102403355133000_27.149.180019.129","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12948-015-0025-9","article-title":"Rituximab in refractory sarcoidosis: a single centre experience","volume":"13","author":"Cinetto","year":"2015","journal-title":"Clin Mol Allergy"},{"key":"2024102403355133000_27.149.180019.130","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e328302c7b6"},{"key":"2024102403355133000_27.149.180019.131","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1148\/rg.2016140339","article-title":"Primary pulmonary lymphoid lesions: radiologic and pathologic findings","volume":"36","author":"Sirajuddin","year":"2016","journal-title":"Radiographics"},{"key":"2024102403355133000_27.149.180019.132","doi-asserted-by":"publisher","DOI":"10.1148\/rg.297095717"},{"key":"2024102403355133000_27.149.180019.133","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000050475","article-title":"Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome","volume":"68","author":"Reichenberger","year":"2001","journal-title":"Respiration"},{"key":"2024102403355133000_27.149.180019.134","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ269"},{"key":"2024102403355133000_27.149.180019.135","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/cei.13012","article-title":"Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group","volume":"190","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"2024102403355133000_27.149.180019.136","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.intimp.2017.09.005","article-title":"Immunoglobulin replacement therapy in primary and secondary antibody deficiency: the correct clinical approach","volume":"52","author":"Pecoraro","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"2024102403355133000_27.149.180019.137","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/cei.12915","article-title":"When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach","volume":"188","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"2024102403355133000_27.149.180019.138","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.12.015"},{"key":"2024102403355133000_27.149.180019.139","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0068-6"},{"key":"2024102403355133000_27.149.180019.140","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00020215"},{"key":"2024102403355133000_27.149.180019.141","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1440-1843.2011.02067.x","article-title":"Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease","volume":"17","author":"Montella","year":"2012","journal-title":"Respirology"},{"key":"2024102403355133000_27.149.180019.142","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-015-0172-2"},{"key":"2024102403355133000_27.149.180019.143","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s10875-015-0227-4","article-title":"Magnetic resonance imaging may be a valuable radiation-free technique for lung pathologies in patients with primary immunodeficiency","volume":"36","author":"Arslan","year":"2016","journal-title":"J Clin Immunol"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0019-2018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:34Z","timestamp":1740355234000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0019-2018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,29]]},"references-count":143,"journal-issue":{"issue":"149","published-online":{"date-parts":[[2018,8,29]]},"published-print":{"date-parts":[[2018,9,30]]}},"alternative-id":["10.1183\/16000617.0019-2018"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0019-2018","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,29]]}}}